COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 3rd May 2020. As a result, our offices will now be closed till 3rd May 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details.,, Mob. 8826373757, 8826859373, 9910947804

Print ISSN:-2454-6704

Online ISSN:-2454-6712


Current Issue

Year 2019

Volume: 5 , Issue: 2

Article Access statistics

Viewed: 646

Emailed: 0

PDF Downloaded: 163

Journal of Preventive Medicine and Holistic Health

Suicidality in epileptics on levetiracetam therapy with preceding comorbidity

Full Text PDF Share on Facebook Share on Twitter

Author Details : Ramesh Kannan

Volume : 3, Issue : 2, Year : 2017

Article Page : 77-78

Suggest article by email


Anti-epileptic medications like levetiracetam, sodium valproate, topiramate and lamotrigine are known to produce serious adverse reactions like suicidal tendencies, Steven Johnson syndrome, toxic epidermal necrolysis, hepatic dysfunction, pacreatitis, depression and psychotic episodes. Here we report two patients who attempted suicide, had psychiatric comorbidity and alcoholism and were on treatment. One patient died and the other was treated for poisoning and survived.
Both the patients were on levetiracetam. It is assumed that levetiracetam could have contributed to the suicidal ideation as an adverse reaction. SUDEP (sudden unexplained death in epilepsy) might as well be considered in the second patient. It is suggested that patients on newer anti epileptics be screened for suicidal intent and treated for psychiatric comorbidity like depression. One of the patients had alcoholism and the other comorbid depression.

Keywords: Levetiracetam, Suicide, Epilepsy, Alcohol dependence, Sudep.

How to cite : Kannan R, Suicidality in epileptics on levetiracetam therapy with preceding comorbidity. J Prev Med Holist Health 2017;3(2):77-78

Copyright © 2017 by author(s) and J Prev Med Holist Health. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (